Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding ImmunityBio, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of IBRX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders116118+2
Shares16.0M27.8M+11.8M (+74.0%)
Value$378.9M$390.1M+$11.2M (+3.0%)

New holders (26)

Institutions that held ImmunityBio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to IBRX in Q2 2021
InstitutionSharesValue% of portfolio
Allen Holding Inc687,571$9.82M1.50%
ClariVest Asset Management LLC216,425$3.09M0.10%
Cubist Systematic Strategies, LLC158,680$2.27M0.03%
Nuveen Asset Management, LLC577,900$1.73M0.00%
Vident Investment Advisory, LLC104,736$1.50M0.05%
Two Sigma Investments, LP85,579$1.22M0.00%
D. E. Shaw & Co., Inc.84,372$1.21M0.00%
Arrowstreet Capital, Limited Partnership65,700$938.0K0.00%
Voloridge Investment Management, LLC60,169$859.0K0.01%
DekaBank Deutsche Girozentrale41,000$577.0K0.00%
GAM Holding AG33,239$475.0K0.02%
Cambridge Investment Research Advisors, Inc.28,568$408.0K0.00%
Pearl River Capital, LLC19,728$282.0K0.08%
Occudo Quantitative Strategies LP19,699$281.0K0.04%
QS Investors, LLC19,500$279.0K0.00%
Handelsbanken Fonder AB16,000$228.0K0.00%
Illinois Municipal Retirement Fund15,973$228.0K0.01%
Quilter Plc12,664$181.0K0.01%
Liberty One Investment Management, LLC12,080$173.0K0.03%
Claro Advisors LLC10,000$143.0K0.06%
Alaethes Wealth LLC5,175$74.0K0.06%
Dark Forest Capital Management LP3,692$53.0K0.02%
Itau Unibanco Holding S.A.2,671$38.0K0.00%
Point72 Hong Kong Ltd310$4.00K0.00%
Tradition Wealth Management, LLC200$3.00K0.00%
BerganKDV Wealth Management, LLC115$2.00K0.00%

Sold out (24)

Institutions that held ImmunityBio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.